Gene Therapy of Liver Diseases: a 2011 Perspective
Overview
Affiliations
Liver diseases including inherited metabolic disorders, chronic viral hepatitis, liver cirrhosis and primary and metastatic liver cancer constitute a formidable health problem because of their high prevalence and the important limitations of current therapies. Gene therapy, a procedure based on the transfer of therapeutic genes to tissues, has been used since the 1990s as a new approach to treating a number of incurable conditions. After a period of lights and shades recent success in treating several devastating diseases like inherited immune deficiency disorders, beta-thalassemia, or inherited blindness appear to herald a new era where gene therapy can be listed among standard therapy options for a wide variety of human conditions. In this review, we provide information illustrating the potentiality of gene therapy in the management of liver diseases lacking other effective therapies.
Gonzalez-Moreno L, Santamaria-Cano A, Paradela A, Martinez-Chantar M, Martin M, Perez-Carreras M Mol Genet Metab Rep. 2023; 35:100967.
PMID: 36967723 PMC: 10031141. DOI: 10.1016/j.ymgmr.2023.100967.
Liver-specific Gene Delivery Using Engineered Virus-Like Particles of Hepatitis E Virus.
Lee E, Kim J, Hur W, Choi J, Kim S, Park D Sci Rep. 2019; 9(1):1616.
PMID: 30733562 PMC: 6367430. DOI: 10.1038/s41598-019-38533-7.
Immunological landscape and immunotherapy of hepatocellular carcinoma.
Prieto J, Melero I, Sangro B Nat Rev Gastroenterol Hepatol. 2015; 12(12):681-700.
PMID: 26484443 DOI: 10.1038/nrgastro.2015.173.
Regulation of hepatocyte identity and quiescence.
Berasain C, Avila M Cell Mol Life Sci. 2015; 72(20):3831-51.
PMID: 26089250 PMC: 11114060. DOI: 10.1007/s00018-015-1970-7.
Lipid nanoparticles for gene delivery.
Zhao Y, Huang L Adv Genet. 2014; 88:13-36.
PMID: 25409602 PMC: 5006671. DOI: 10.1016/B978-0-12-800148-6.00002-X.